NCT01521767View on ClinicalTrials.gov

Pharmacokinetics and Relative Bioavailability Study

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

tolterodine tartrate

4 mg single dose of extended release capsules

DRUG

tolterodine tartrate

4 mg single dose of microspheres in powder blend

DRUG

tolterodine tartrate

4 mg single dose of microspheres in powder blend

DRUG

tolterodine tartrate

4 mg single dose of microspheres in powder blend

DRUG

tolterodine tartrate

4 mg single dose of microspheres in powder blend

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01521767 - Pharmacokinetics and Relative Bioavailability Study | Biotech Hunter | Biotech Hunter